Petros Pharmaceuticals, Inc. (PTPI)
Chart Events
Performance Outlook
| Previous Close | 1.9500 |
| Open | 1.8500 |
| Bid | 1.7000 x 1300 |
| Ask | 1.7100 x 900 |
| Day's Range | 1.5700 - 1.9750 |
| 52 Week Range | 0.9170 - 9.5400 |
| Volume | |
| Avg. Volume | 365,023 |
| Market Cap | 3.593M |
| Beta (5Y Monthly) | 2.07 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.2900 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for PTPI
Related Research
- Petros Pharmaceuticals, Inc.Daily – Vickers Top Insider Picks for 10/03/2023The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.RatingFair ValueEconomic Moat7 hours agoArgus Research
ACCESSWIREPetros Pharmaceuticals to Present at the LD Micro Main Event XVI
NEW YORK, NY / ACCESSWIRE / September 28, 2023 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI), a company focused on expanding consumer access to medication through over the counter (OTC) pathway, announces today that Fady Boctor, President and Chief ...
- ACCESSWIRE
Petros Pharmaceuticals Provides Letter to Shareholders
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over the counter (OTC) pathway provides the below Letter to Shareholders:
- ACCESSWIRE
Petros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
/ Petros Pharmaceuticals, Inc. (Nasdaq:PTPI), a pioneer in expanding consumer access to medication through over the counter (OTC) pathways, announces today that Fady Boctor, President and Chief Commercial Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference.
